Cuprina Holdings (Cayman) Limited Class A Ordinary Shares CUPR
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares SYBX
Synlogic, Inc. LSTA
Lisata Therapeutics, Inc. LIXT
Lixte Biotechnology Holdings, Inc. HOTH
Hoth Therapeutics, Inc. APLM
Apollomics, Inc. CLSD
Clearside Biomedical, Inc. LNAI
Lunai Bioworks Inc. BCTX
BriaCell Therapeutics Corp. PCSA
Processa Pharmaceuticals, Inc.
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares SYBX
Synlogic, Inc. LSTA
Lisata Therapeutics, Inc. LIXT
Lixte Biotechnology Holdings, Inc. HOTH
Hoth Therapeutics, Inc. APLM
Apollomics, Inc. CLSD
Clearside Biomedical, Inc. LNAI
Lunai Bioworks Inc. BCTX
BriaCell Therapeutics Corp. PCSA
Processa Pharmaceuticals, Inc.
Performance
| Periode | CUPR | SYBX | LSTA | LIXT | HOTH | APLM | CLSD | LNAI | BCTX | PCSA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -80.15 % | 74.53 % | 8.34 % | 262.10 % | 81.81 % | 445.18 % | -67.17 % | -47.01 % | -70.64 % | 35.00 % |
| YTD | -76.80 % | 30.28 % | -30.81 % | 102.25 % | 82.15 % | 198.33 % | -72.51 % | -47.01 % | -85.86 % | -67.01 % |
| 1Y | -76.80 % | 28.47 % | -17.11 % | 133.85 % | 59.40 % | 135.53 % | -80.10 % | -47.01 % | -89.70 % | -78.94 % |
| 3Y | -76.80 % | -88.47 % | -40.62 % | -19.82 % | -83.26 % | -96.82 % | -76.12 % | -47.01 % | -98.68 % | -99.26 % |
| 5Y | -76.80 % | -93.92 % | -90.20 % | -93.55 % | -96.92 % | -96.75 % | -81.76 % | -47.01 % | -70.57 % | -99.66 % |
| 10Y | -76.80 % | -95.46 % | -98.74 % | -53.23 % | -99.34 % | -96.75 % | -96.38 % | -47.01 % | 11 941 747 572 715.53 % | -99.65 % |
| Depuis le début | -76.80 % | -43.43 % | -100.00 % | -99.83 % | -99.34 % | -96.75 % | -96.38 % | -47.01 % | 1 883 614 088 720.83 % | -99.92 % |